Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_assertion description "[Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_assertion evidence source_evidence_literature NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_assertion SIO_000772 23396606 NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_assertion wasDerivedFrom befree-20150227 NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_assertion wasGeneratedBy ECO_0000203 NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP570648.RAOt1wwd2lETVzaGFhuc1ZgpJ0j0eocG4bkcLDJdB06aU130_provenance.